Each material 8-K filed by a company listed on a US stock exchange (NYSE, Nasdaq, Cboe), read and summarized: what happened, the key numbers, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). This page lists the last 45 days; every brief stays on its company's 8-K page (3297 companies, A–Z).
On November 5, 2026, Inovio agreed to sell 58,747,235 common shares at $1.05 each and pre-funded warrants for 12,681,337 shares at $1.049 each, and on November 6 the underwriters exercised their option to buy 10,714,285 more shares in full. Net proceeds are expected to be about $80.5 million, with closing expected on or about November 9, 2026. The sale adds to the shares outstanding, which dilutes existing holders, but the company says the proceeds and current cash will fund operations into late fourth quarter 2027.
58,747,235 common shares sold at $1.05 per share, plus pre-funded warrants for 12,681,337 shares at $1.049 each
Underwriters exercised their option for 10,714,285 additional shares in full on November 6, 2026
Net proceeds expected to be about $80.5 million; closing expected on or about November 9, 2026
Company believes proceeds and current cash will fund operations into late fourth quarter 2027
Akamai announced a proposed private offering of $1.1 billion of 2028 convertible senior notes and $1.1 billion of 2031 convertible senior notes, subject to market conditions. On November 5, 2026, it also amended its credit agreement, raising the maximum leverage ratio covenant and tightening the limit on secured subsidiary debt, which the filing says applies through March 31, 2028.
Two $1.1 billion offerings: 2028 notes maturing November 15, 2028, and 2031 notes maturing November 15, 2031, with an option for initial purchasers to buy up to an additional $150.0 million of each series.
Proceeds are intended to repay part of the $1.15 billion 0.375% convertible notes due September 1, 2027, fund Cloud Infrastructure Services capital expenditures, pay hedge costs, and for general corporate purposes.
Fourth Amendment dated November 5, 2026, with JPMorgan Chase Bank, N.A. as agent, sets the maximum leverage ratio at 6.25:1.00 for quarters ending December 31, 2026 and March 31, 2027, stepping down to 3.75:1.00 for the quarter ending March
Akamai states there is no assurance the offering will be completed on the anticipated terms, or at all; pricing terms are yet to be set.
Vivid Seats reported third-quarter 2026 revenue of $126.9 million, down from $136.4 million a year earlier, while its net loss narrowed to $17.4 million from $19.7 million and adjusted EBITDA rose to $8.9 million from $4.9 million. The company also reached an agreement in principle with an ad hoc group of term lenders on a recapitalization that would provide $60 million of new money term loans, convert a significant portion of existing debt into equity, and cut funded debt by about $200 million, subject to definitive documentation.
Q3 2026 revenue was $126.9 million versus $136.4 million in Q3 2025; net loss was $17.4 million versus $19.7 million.
Adjusted EBITDA was $8.9 million versus $4.9 million; Marketplace GOV was $624.0 million versus $618.1 million.
Proposed transaction includes $60 million of new money term loans, conversion of a significant portion of debt into equity, a reduction of about $200 million in funded debt, and an extended maturity on remaining debt.
2026 outlook was continued: Marketplace GOV of $2.3 billion to $2.6 billion and adjusted EBITDA of $34.0 million to $40.0 million; the transaction remains subject to definitive documentation.
CKX Lands and Jacobs Private Equity II agreed to a definitive investment agreement providing for a $1 billion cash equity investment in CKX. After closing, JPE will be the controlling stockholder and Brad Jacobs will become chairman and CEO, and the filing describes substantial dilution from convertible preferred stock and warrants. The deal requires CKX stockholder approval and is expected to close in early 2027.
$1 billion total investment: $900 million from JPE and $100 million from co-investors led by HRTG Partners
Upon closing, JPE will hold a majority stake and Brad Jacobs will become chairman and CEO of CKX
Investors would receive convertible preferred stock convertible into about 219 million common shares at $4.57 per share, plus warrants for about 219 million shares
CKX will declare an aggregate cash dividend of $20.8 million, or $10.1312 per share, with a record date shortly before closing; closing is expected in early 2027
Gogo and its subsidiary GIH signed a third amendment to their 2021 credit agreement, converting $544.4 million of term loans into new 2026 Extended Term Loans that mature October 31, 2030. The amendment requires $75 million of prepayments through December 31, 2027 and sets a higher interest margin of 5.75% over SOFR, so shareholders gain more time on debt maturities but pay more in interest and face required debt repayments.
2026 Extended Term Loans of $544.4 million mature October 31, 2030; Initial Term Loans of $33.4 million mature April 30, 2028
Required prepayments: $25.0 million on the November 6, 2026 closing date, $30.0 million by December 31, 2026, and $20.0 million by December 31, 2027
Interest at SOFR plus 5.75% or an alternate base rate plus 4.75%; quarterly amortization begins March 31, 2027
Amendment adds certain foreign subsidiaries as guarantors and grants additional collateral on a pari passu basis with the HPS Credit Agreement
NextNRG, Inc. closed a debt exchange on November 3, 2026, in which CEO Michael D. Farkas exchanged $7,000,000 of notes, interest and guarantee fees for 7,000 shares of newly designated Series D Convertible Voting Preferred Stock. The company says this reduces indebtedness and supports its efforts to meet Nasdaq's $2.5 million stockholders' equity requirement, but the filing states that the exchange alone does not satisfy that requirement. The Series D shares accrue an 18% annual cumulative dividend, are convertible into common stock at an initial $2.20 price, and carry voting rights, which may dilute common shareholders.
Exchange covered $3,629,924 in note principal, $2,749,169 in accrued interest and $620,907 in guarantee fees, with the closing on November 3, 2026
7,000 Series D shares carry an initial stated value of $1,000 per share, with a cumulative dividend of 18% a year compounding monthly
Initial conversion price is $2.20 per share; conversion and voting are capped at 1,684,224 shares, or 9.99%, until the Cap Release Date
Nasdaq requires at least $2.5 million in stockholders' equity; the exchange alone does not satisfy that requirement, and the company awaits a Nasdaq Hearings Panel decision
3D Systems agreed on November 4, 2026 to exchange all $92,030,000 of its 5.875% convertible senior secured notes due 2030 for $85,000,000 of new 3.30% convertible notes due 2031, 13,471,138 common shares and $20,000,000 in cash. The company says the exchange would eliminate all secured debt, and it expects to close on or about November 12, 2026, subject to conditions. Shareholders face potential dilution from the new shares and the up to 32,196,963 shares that could be issued on conversion, and the company receives no cash proceeds from the exchange.
Exchange covers all $92,030,000 of 2030 Notes; holders receive $85,000,000 of 3.30% notes due April 1, 2031, 13,471,138 shares and $20,000,000 in cash
New notes carry an initial conversion price of about $3.43, a premium of about 30.0% over the $2.64 closing price on November 4, 2026
Closing expected on or about November 12, 2026; closing may be postponed to November 19 or December 4, 2026, and the agreements terminate if closing has not occurred by December 15, 2026
The company will not receive any cash proceeds from the exchange
AAR CORP. distributed a preliminary offering memorandum for $955 million of senior notes due 2031 and $960 million of senior notes due 2034, sold only to qualified institutional buyers and certain non-U.S. persons. The notes are one part of the transactions that include the pending acquisition of a 65% stake in MRO Holdings, which has an implied enterprise value of about $4.0 billion, so the deal adds about $1.9 billion of debt for shareholders to weigh against the target's recent results, which show higher revenue but lower net income.
Acquisition: AAR would acquire 6,500 shares, or 65%, of MRO Holdings at an implied enterprise value of about $4.0 billion under a Share Purchase Agreement dated September 28, 2026
MRO Holdings, six months ended June 30, 2026 (IFRS, unaudited): revenue $489.1 million vs. $465.8 million a year earlier; net income $38.1 million vs. $63.8 million
Intrusion Inc. exchanged $4.0 million of secured promissory notes held by Streeterville Capital for 4,000 shares of newly designated Series B Preferred Stock, with no other consideration exchanged. The company said the exchange lifts its stockholders' equity above $5.0 million, which it believes allows it to request a second 180-day Nasdaq extension to regain compliance with the $1.00 minimum bid price, though Nasdaq may not grant it. The Series B shares carry a 10% annual preferred return and rank senior to common stock, and their protective covenants restrict the company's future debt and equity issuance.
Notes of $3.25 million and $750,000, partitioned from April 6, 2026 and August 28, 2026 notes, were exchanged for 4,000 Series B shares with a $1,100 stated value each, cancelling $4.0 million of principal.
Series B Preferred Stock is non-voting and non-convertible, accrues a 10% annual preferred return, and ranks senior to common stock on dividends and liquidation.
Protective covenants bar the company from incurring debt, issuing equity, or completing reverse splits (other than for Nasdaq compliance) without majority Series B consent.
The company believes it qualifies for a second 180-calendar-day Nasdaq extension, but states there can be no assurance Nasdaq will grant it.
Broadcom said financial partners took on part of certain agreements to buy AI racks built on its custom accelerators, along with related customer leases. The company is providing residual value support to a newly formed special purpose vehicle, with maximum potential liability of approximately $43 billion on an undiscounted basis once the racks are deployed. Shareholders face a large contingent obligation, which the company says it views as having a low probability of occurring.
Arrangement dated October 26, 2026, with financial partners taking on a portion of AI rack purchase agreements and related customer leases
Residual value support provided to a newly formed special purpose vehicle called the Backstop
Maximum potential liability of approximately $43 billion, undiscounted, upon deployment of the AI racks
Potential liability equals the difference between 72.5% of outstanding lease amounts and the value of the racks sold
Endovia Health Sciences entered into an addendum on October 22, 2026, to its equity line of credit with C/M Capital Master Fund, LP, raising the total maximum commitment from $35 million to $135 million, including prior sales. The addendum also sets updated terms for sales made beyond the initial 10,875,000 shares already sold and issued under the agreement, which affects how much new common stock the company may issue over time.
Addendum dated October 22, 2026, amends the Securities Purchase Agreement dated September 19, 2025, with C/M Capital Master Fund, LP
Total maximum commitment increases from $35 million to $135 million, inclusive of prior sales
Updated terms apply to sales above the initial 10,875,000 shares sold and issued under the agreement
Original agreement was filed as Exhibit 10.3 to a Form 8-K on September 25, 2025
GeoVax entered a revolving loan agreement dated October 25, 2026 with Bowery Consulting Group Inc. for up to $1 million outstanding at one time, at 12% interest, with no amount borrowed as of the filing. The lender can refuse any drawdown at its sole discretion, and either party can terminate the commitment. Five directors resigned effective October 23, 2026, and three lender-designated nominees now make up three of the five board seats, so shareholders should note both the costly, contingent financing and the shift in board control.
Loan facility of up to $1 million at 12% per annum, due on the first anniversary of closing; no amount borrowed as of the filing date
Lender may refuse any drawdown in its sole discretion, and either party may terminate the commitment at any time
Directors Randal Chase, Dean Kollintzas, Nicole Lemerond, Jayne Morgan and John Spencer, Jr. resigned effective October 23, 2026; Steven Brown, Tyler O'Brien and Manpreet Uppal were appointed as lender nominees
Nominees automatically resign if the initial public equity offering is not closed within ten business days after the S-1 becomes effective, or if at least $10 million in total financing is not completed by December 31, 2026
Invesco Ltd. borrowed the full $1.5 billion of an unsecured five-year term loan on October 26, 2026, and used it to repurchase $1.5 billion of its 5.9% preference shares held by MassMutual, a significant shareholder owning about 18.5% of common shares. The repurchase was made at a 12.5% premium to the $1,000 liquidation preference, and MassMutual will keep $1 billion of preferred stock. The loan adds debt that carries financial covenants, so it changes the company's debt load and its obligations ahead of common shareholders.
$1.5 billion unsecured term loan dated October 26, 2026, maturing October 26, 2031, borrowed in full at closing and guaranteed by Invesco Ltd.
Proceeds funded repurchase of $1.5 billion of 5.9% Series A Preference Shares from MassMutual at a 12.5% premium to the $1,000 liquidation preference per share.
Loan interest is Term SOFR or a base rate plus a margin; based on current credit ratings, the SOFR margin would be 1.350%.
Quarterly covenants require a Debt/EBITDA ratio of no more than 3.25:1.00 and interest coverage of at least 4.00:1.00.
On October 20, 2026, iQSTEL issued senior secured, non-convertible promissory notes of up to $3 million in aggregate to M2B Funding Corp. and ADI Funding LLC, along with pre-funded warrants for 420,000 shares, to help fund its planned 51% acquisition of Ultranet Telecom Group. The notes carry 18% annual interest and are secured by a first-priority interest in company collateral, and the warrants could add dilution, so the financing adds debt cost and potential share issuance for shareholders while the acquisition itself is not yet signed.
Up to $3 million in notes, split between two purchasers: first $750,000 per purchaser funded on or about October 20, 2026, and a second advance of up to $750,000 per purchaser due on or before December 1, 2026
Notes bear 18% annual interest payable monthly in cash; principal repaid in four equal installments over 24 months
Warrants for 420,000 shares at a $0.0001 exercise price were fully issued at the initial closing; holders may accelerate at 120% of funded principal after an uncured default
Company expects to sign the Ultranet share purchase agreement in November 2026 and target closing in the middle of the first quarter of 2027
Peraso Inc. agreed on October 26, 2026 to sell shares, pre-funded warrants and common warrants to Nant Capital, LLC for expected gross proceeds of about $10 million, before offering expenses. The deal, expected to close on or about October 28, 2026, adds cash but also issues a large number of new shares and warrants, which would dilute existing shareholders. It also gives Nant the right to designate board members while its stake stays at or above 5% of outstanding common stock.
Units priced at $0.5034, including Shares, Pre-Funded Warrants and Common Warrants; 3,271,355 shares and pre-funded warrants for 16,593,563 shares, plus common warrants for up to 19,864,918 shares
Common warrants have an exercise price of $0.3784 per share and a two-year term from issuance
Nant may designate two board members while it owns at least 16.7% of common stock, and one while it owns at least 5% but less than 16.7%; no designee has been appointed yet
Closing expected on or about October 28, 2026, subject to closing conditions; proceeds are for working capital and general corporate purposes
Traws Pharma entered a Common Stock Purchase Agreement with Roth Principal Investments, allowing the company to sell up to $50,000,000 of newly issued common stock over time at its own discretion. The company is under no obligation to sell any shares, and sales can begin only after a registration statement covering the resale of those shares is declared effective by the SEC.
Total commitment of up to $50,000,000 in newly issued common stock, at the company's option
Purchase price set at 94.0% of volume weighted average price, a fixed 6.0% discount, for market open, intraday, pre-market and post-market purchases
Sales require the closing price to be at least $0.10 (Threshold Price) and an effective registration statement; the period runs 36 months from the Commencement Date
Agreement dated October 23, 2026, with a related Registration Rights Agreement
On October 15, 2026, subsidiary NCL Corporation closed a $950.0 million offering of 8.750% senior notes due 2031, with net proceeds of approximately $941.7 million. The company used the proceeds, with cash on hand, to redeem its 6.125% notes due 2028 and to repay and prepay other borrowings, and it amended its revolving credit facility to raise lender commitments to $2,801.0 million. For shareholders, the filing shows a debt refinancing and a larger revolver, but the new notes carry a higher interest rate than the notes they replaced.
$950.0 million of 8.750% senior notes due October 15, 2031 closed October 15, 2026; net proceeds approximately $941.7 million before estimated fees and expenses.
Proceeds, with cash on hand, used to redeem all outstanding 6.125% notes due 2028 and to repay approximately $376.3 million of revolver borrowings and prepay approximately $42.2 million of export-credit facilities.
Revolving loan commitments increased from $2,486.0 million to $2,801.0 million; maturity is January 22, 2030, subject to conditions tied to 2027 exchangeable notes.
Pride of America Ship Holding and Norwegian Epic were added as guarantors; Norwegian Dawn and Norwegian Spirit were released as guarantors.
Recursion agreed to sell 61,540,000 new Class A common shares at $3.25 each, for expected gross proceeds of about $200 million, with closing expected October 16, 2026. The company also reported preliminary cash of about $561 million as of September 30, 2026, which it says will fund operations into 2029, and released updated Phase 1b/2 data for REC-4881 and news of a Sanofi option on a development candidate.
Offering of 61,540,000 Class A shares at $3.25 per share, with expected gross proceeds of about $200 million before fees and expenses, closing expected October 16, 2026
Executive officers and directors agreed to a 45-day lock-up on sales of company securities, subject to exceptions
Preliminary cash, cash equivalents and restricted cash of about $561 million as of September 30, 2026; company expects funding into 2029
Sanofi optioned a development candidate, triggering a $10 million milestone payment and bringing total collaboration payments to $144 million
Wheeler Real Estate Investment Trust entered into a Note Purchase Agreement on October 13, 2026, to issue promissory notes totaling up to $25 million in principal, with the initial note at $1 million. The notes carry 0.00% interest, mature 18 months after issuance, and require amortization payments that can be made in common stock, which could dilute existing shareholders, subject to stockholder approval and an effective registration statement.
Initial Note Investor purchase: $1,000,000 principal note; maximum aggregate principal of up to $25,000,000 across Notes.
Notes bear 0.00% interest and mature 18 months after issuance; amortization payment set at 0.4% of original principal per trading day, adjustable between 0.2% and 0.6%.
Amortization payments are paid in common stock at market value, or in cash if the price is below $0.25 per share or other listed conditions are not met.
Closing requires stockholder approval for issuance above 19.99% of outstanding common stock and an effective resale registration statement; purchase price is paid in Series D Preferred Stock at $25.00 liquidation preference.
SS Innovations International entered a Securities Purchase Agreement on October 9, 2026, issuing a secured convertible promissory note with a $21,025,000 principal amount for a $20,000,000 purchase price. The note bears 8.75% interest, matures 36 months after closing, and is secured by the company's intellectual property and most subsidiary assets, which could dilute existing shareholders through conversions.
Note issued October 9, 2026 with $21,025,000 principal for a $20,000,000 purchase price, including $1,000,000 original issue discount and $25,000 investor expenses
Interest at 8.75% per annum compounded daily; matures 36 months after the Closing Date
Investor may convert at 95% of Market Price beginning on the Effective Date; company reserved an initial 8,000,000 common shares for conversions
Note secured by company IP held by SSI IP Holdings and assets of the company and SS IP; Indian subsidiary SSI-India excluded from collateral
DENTSPLY SIRONA obtained lender consent and amended its revolving credit facility and three note purchase agreements, effective around September 30, 2026. The changes raise the maximum permitted leverage ratios for the quarters ending September 30 and December 31, 2026, and add tighter limits on new liens, subsidiary debt and restricted payments. The company says the revised terms are intended to keep it in compliance with its debt covenants in all material respects.
Maximum permitted Total Leverage Ratio and Senior Leverage Ratio increased for fiscal quarters ending September 30, 2026 and December 31, 2026.
Until the compliance certificate for fiscal 2026 is delivered, new liens and new subsidiary debt are generally prohibited, and restricted payments are limited with certain carveouts.
Credit facility adds a new pricing level for the applicable margin and facility fee; note interest increases if leverage meets specified thresholds.
Wolfspeed announced a conditional commitment letter with the U.S. Department of War's Office of Strategic Capital for a senior secured delayed-draw term loan of up to $1.5 billion. Entry into the facility depends on due diligence, definitive agreements, government approvals and conditions such as raising at least $750 million of qualifying sources and issuing warrants for up to 7.5% of fully diluted equity.
Facility of up to $1.5 billion with a currently expected 30-year maturity and a 36-month draw period; initial tranche of $600 million would refinance first lien senior secured notes due 2030
Provisional risk premium of 1.25% to 1.75% over a comparable U.S. Treasury rate, subject to final agreements
Company must raise a Minimum Contribution of at least $750 million, including $50 million before the facility's effective date, and issue warrants to the DoW for 5% and 2.5% of outstanding equity
Filing states no assurance that definitive agreements will be signed or that financing will be provided
Rocket Pharmaceuticals entered a Loan and Security Agreement with Hercules Capital on September 30, 2026, providing up to $150.0 million in senior secured term loans, with $35.0 million funded at closing. The company also issued warrants to the lenders for 1,755,853 shares of common stock at $2.99 per share, which adds potential dilution, and the loans are secured by substantially all of the company's assets.
Tranche 1-A advance of $35.0 million funded September 30, 2026; further tranches total up to $115.0 million at the company's option or the lenders' approval
Loans mature October 1, 2030, with interest at the greater of prime or 6.75%, plus 2.40%
Warrants for 1,755,853 shares at $2.99 per share; 409,699 shares exercisable after the Tranche 1-A funding
Prepayment charges of 3.00%, 2.00% or 1.00% depending on timing; minimum cash covenant not tested while market capitalization exceeds $600.0 million
Rocky Mountain Chocolate Factory agreed to sell its Durango, Colorado property, which serves as its corporate headquarters and production and warehouse facility, to American Heritage Legacies, LLC for $6.6 million, and will lease it back for 10 years. The buyer is controlled by the family of Interim CEO Allen Harper, making the deal a related party transaction, and proceeds will repay $6.6 million of notes at 12% annual interest held by entities affiliated with board members Steven L. Craig and Jeffrey R. Geygan, which reduces debt but commits the company to rent and a possible buyback obligation if control changes.
Sale price is $6.6 million; closing is expected on or about October 15, 2026, with an independent appraisal supporting the price
Net proceeds are expected to repay $6.6 million of notes accruing 12% per annum, held by RMC Credit Facility LLC and RMCF2 Credit, LLC
Lease has a 10-year initial term, first-year annual rent of $624,000 rising 2% a year, and an option to renew for 10 more years
On a change of control, the lease terminates and, at the landlord's option, the company must buy back the property for the greater of $6.93 million or appraised value
Neighborhood Intelligence sold about 10.9 million common shares plus pre-funded and common warrants in a registered direct offering that closed October 6, 2026, with approximately $42.6 million in net proceeds. The company also cut its at-the-market program ceiling from $200 million to $75 million, and its Executive Chairman and CEO bought shares at the same $2.76 price, so the offering adds share count and potential dilution for existing holders.
Offering of 10,881,192 common shares at $2.76 per share, plus pre-funded warrants for 5,241,997 shares and common warrants for 16,123,189 shares, closed October 6, 2026.
Net proceeds of approximately $42.6 million, which the company intends to use to accelerate merger synergies and build inventory.
Maximum aggregate offering price under the at-the-market program reduced from $200,000,000 to $75,000,000 on October 5, 2026.
Company and directors and executive officers agreed to lock-ups of 90 days after closing; Marcus Lemonis bought 362,319 shares at $2.76.
NN, Inc. closed a private placement on October 5, 2026, selling 11,275,605 common shares and pre-funded warrants for up to 4,824,395 shares at $3.30 per share, for about $50 million in net proceeds. The company said most proceeds will redeem its remaining Series D Preferred Stock, and the rest will fund business growth; shareholders face potential dilution from the new shares and resale registration.
Gross proceeds of about $53 million; net proceeds of about $50 million after a 6.0% placement agent fee and expenses
Closed October 5, 2026; 93,744,210 common shares outstanding immediately after issuance
Majority of net proceeds to redeem remaining Series D Preferred Stock; company must file resale registration statement within 45 days
Gold.com entered into a Second Amended and Restated Credit Agreement with CIBC Bank USA as administrative agent on September 29, 2026. The uncommitted revolving line is payable on demand and is reduced from $427.5 million to $250 million, while many caps on dividends, buybacks, acquisitions and metals-related arrangements are removed or loosened.
Facility reduced from $427,500,000 to $250,000,000
Converted to an uncommitted revolving line of credit payable on demand
Caps on special and recurring dividends and share repurchases removed, subject to conditions
Agreement dated September 29, 2026; filed October 2, 2026
Veritone agreed on September 30, 2026 to sell 20,000,000 shares of common stock to purchasers in a registered direct offering, with expected gross proceeds of $15.0 million before offering expenses. The company plans to use the net proceeds, together with existing cash, to repay or restructure part of its convertible debt and for working capital, and the forward-looking statements cite its 1.75% convertible senior notes due November 2026. The new shares add to the existing share count, while the filing says the proceeds are intended to address debt maturing later this year.
Issuance of 20,000,000 shares of common stock at $0.001 par value under an effective Form S-3 shelf registration
Expected gross proceeds of $15.0 million before offering expenses
Closing expected on or about October 2, 2026, subject to customary closing conditions
Proceeds intended to repay or restructure part of convertible debt, including 1.75% convertible senior notes due November 2026 referenced in the filing
KLX Energy Services completed its subscription rights offering on September 29, 2026, selling 24,975,001 shares at $1.49 each for $37.2 million in gross proceeds. Backstop holders of its 2030 Notes exchanged them for 59,273,445 shares, cutting outstanding principal by $94.0 million, and the company expects 105,677,168 shares outstanding afterward, so existing shareholders will be diluted. The 2030 Notes indenture was also amended to loosen leverage tests, which gives the company more covenant flexibility.
Rights offering: 24,975,001 shares sold at $1.49 per share for $37.2 million gross; $31.0 million for general corporate purposes and $6.2 million to redeem 2030 Notes at par on October 10, 2026
Backstop exchange: 59,273,445 shares issued to Backstop Parties; 2030 Notes principal reduced by $94.0 million; 105,677,168 shares expected outstanding
Indenture amended: total net leverage incurrence test relaxed from 2.50:1.00 to 3.00:1.00; maintenance covenant step-down reset to 4.50:1.00 starting with the quarter ending September 30, 2026
Summit Therapeutics agreed on September 28, 2026 to sell 108,955.3686 shares of Class A Convertible Preferred Stock to AstraZeneca Holdings B.V. for $2.0 billion in gross proceeds, and also signed a separate clinical trial collaboration with AstraZeneca on sonesitatug vedotin combined with ivonescimab. Shareholders would face dilution once the preferred converts into common stock, which is subject to conditions and a registration statement, and the company must redeem the preferred for cash if a required share authorization is not effective within 18 months.
Purchase price of $18,356.14 per preferred share, based on a common stock price of $18.3561; each preferred share converts into 1,000 common shares
Closing is expected within five business days of the Purchase Agreement, subject to customary conditions
Conversion is barred until the later of any Hart-Scott-Rodino waiting period expiration and effectiveness of the authorized share increase charter amendment
Company must file a resale registration statement within 60 days after closing; cash redemption required if the share increase is not effective within 18 months
Sabre Financial Borrower, a Sabre subsidiary, issued $1.35 billion of 9.875% senior secured notes maturing October 15, 2032, and used the proceeds to refinance part of Sabre GLBL's debt and repurchase portions of its 10.750% and 11.125% notes due 2029 through tender offers. The filing also reports early tender results showing more than 90% of a separate 11.125% note series tendered, which the company plans to redeem, so the refinancing reshapes Sabre's debt structure and secured creditor position.
SPV Notes: $1.35 billion principal, 9.875% annual interest, payable April 15 and October 15, maturing October 15, 2032
Sabre GLBL accepted about $251.9 million of 10.750% 2029 notes at $992.50 per $1,000 principal, with proration of about 84.0%
Early tender results: $930.7 million, or 93.07%, of the 11.125% 2029 notes tendered by September 25, 2026; redemption expected October 13, 2026
Settlement of the tender offers is expected September 28, 2026
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Frequently asked questions
Which filings get a brief?
Form 8-K filings by companies listed on a US stock exchange (NYSE, Nasdaq, Cboe; not over-the-counter stocks) that report a material event: results (Item 2.02), deals (1.01, 2.01), executive changes (5.02), restructuring (2.05), impairments (2.06), delisting notices (3.01), restatements (4.02), cybersecurity incidents (1.05), bankruptcy (1.03) and Regulation FD or other events (7.01, 8.01). Routine filings such as vote results or exhibits only are skipped.
How is the impact score set?
The AI rates each filing from 1 (routine) to 5 (major, such as a merger, bankruptcy or restatement) based only on what the filing says. It is a reading aid for sorting the day's filings, not a prediction of how the stock will move.
How quickly do briefs appear?
On weekdays the SEC filing feed is checked every 5 minutes from 6 am to 5:45 pm Eastern, when nearly all 8-Ks come in, and every hour after that until 10 pm. Briefs of the 1,000 largest companies follow within minutes; the others usually within the hour, or later the same day when many filings arrive at once.
Which companies are covered?
Every company with shares listed on the NYSE, Nasdaq or Cboe that files 8-Ks, about 4,500 of them. Foreign companies that report on Form 6-K instead are not included. The S&P 1500 only filter above narrows the list to the large, mid and small caps of the S&P Composite 1500.
Are older briefs kept?
Yes. This page shows the last 45 days, but every brief ever published stays online: each has its own page, and each company has an 8-K page listing all of its briefs, newest first, linked from its stock page and from the A-Z list of companies.